The global preclinical CRO market size was valued at US$ 4.53 billion in 2020 and is expected to grow at a CAGR of 8.2% from 2021 to 2028

The global preclinical CRO market size was valued at US$ 4.53 billion in 2020 and is expected to grow at a CAGR of 8.2% from 2021 to 2028; and is expected to reach US$ 8.52 billion by 2028. Preclinical CRO renders research and development providing experience, learning and aptitude essential for medical and pharmaceutical equipment during designing phase to distribution. Lifesaving drugs are also needed to be developed and should be available in the market owing to increasing cases of R&D expenditure. Biopharmaceutical and pharmaceutical industry play a vital role at the global level owing to increasing number of drugs and soaring R&D expenses which is expected to stimulate the preclinical CRO market growth during the forecast period.

Report published by Servier Research Institute, about 50% of preclinical failure phase arises owing to toxicology which would push the prerequisite for the preclinical CRO services during the forecast period. However, skilled workforce, low-cost devices, competitiveness among key players and rising cases of chronic diseases would fuel up the market revenue share. Surge in the new and complex microorganism causes several different unknown diseases thus augments for the development of newer drugs by the key competitor companies.

North American regions accounts for the soaring revenue share owing to immense investments towards well developed healthcare infrastructure coupled with outsourcing the R&D activities. Asia- pacific region also accounts lucrative market for the growth of global preclinical CRO market owing to soaring cases for chronic health conditions which includes cardiac diseases, diabetes and cancer. Concerns comprising drug safety and efficacy for the adoption of preclinical CRO by government will pitch the market growth. In addition, preclinical testing in oncology and increasing number of investigational new drugs bolstering the necessity for the preclinical CRO market in the region during the forecast period.

Prominent player inducing the Global Preclinical CRO Market among other includes

  • Envigo Corporation
  • MPI Research
  • Eurofins Scientific
  • IQVIA
  • PAREXEL International Corporation
  • Charles River
  • ICON PLC
  • PRA Health Sciences
  • Medpace
  • Laboratory Corporation of America Holding
  • Pharmaceutical Product Development
  • LLC
  • WuXi AppTec
  • MD Biosciences 

Preclinical CRO Market Segmentation:

By Service

  • Bioanalysis and Drug Metabolism Pharmacokinetics (DMPK) Studies
    • In Vitro ADME
    • In-vivo pharmacokinetic (PK)
    • Toxicology Testing
      • GOOD Laboratory Practice (GLP)
      • Non-GLP
      • Compound Management
        • Process R&D
        • Custom Synthesis
        • Others
        • Chemistry
          • Medicinal Chemistry
          • Computation Chemistry
          • Safety Pharmacology
          • Others

By End-user

  • Biopharmaceutical Companies
  • Government and Academic Institutes
  • Medical Device

By Region

  • North America
    • US
    • Canada
    • Rest of North America
    • Europe
      • UK
      • Germany
      • France
      • Spain
      • Italy
      • Rest of Europe (RoE)
      • Asia Pacific
        • Japan
        • China
        • India
        • Rest of Asia Pacific
        • Rest of the World (RoW)
          • South & Central America
          • Middle East
          • Africa